Welcome to HPR LLP; where science meets impact. Our services accelerate medical progress, elevate patient well-being, and empower sponsors with trusted, transparent collaboration every step of the way.
Hippocratic Pharma Research LLP (HPR) accelerates global medical progress by merging cutting-edge biomedical research with strict ethical standards. Our core purpose is to put patient welfare first, driving the discovery of safe and effective therapies that address critical unmet medical needs worldwide. We are guided by scientific integrity, transparency, and robust governance in everything we do.
We transform complex scientific information into decisive action for pharmaceutical teams. We do this by integrating diverse data clinical, real-world, and molecular and providing real-time analytics. By empowering our partners with actionable insights, we help de-risk drug trials, speed up development, and optimize market strategies, ensuring evidence-based communication and continuous safety monitoring from early research to post-market care.
.
We deliver exceptional service by prioritizing client needs, ensuring clear communication, and customizing solutions for measurable outcomes.
Our culture champions creativity, translating complex scientific data into engaging and highly impactful healthcare communication and campaigns.
Our team thrives on collaboration, blending medical, creative, regulatory, and communication experts to deliver comprehensive client solutions.
The work is dynamic and fast-paced, requiring adaptability and resilience to manage rapid project timelines in the high-stakes healthcare industry.
These core pillars create a distinctive, client-centered model that enables our partners to confidently achieve their objectives with clarity and continuity.
We deliver exceptional service by prioritizing client needs, ensuring clear communication, and customizing solutions for measurable outcomes.
Our culture champions creativity, translating complex scientific data into engaging and highly impactful healthcare communication and campaigns.
Our team thrives on collaboration, blending medical, creative, regulatory, and communication experts to deliver comprehensive client solutions.
The work is dynamic and fast-paced, requiring adaptability and resilience to manage rapid project timelines in the high-stakes healthcare industry.
These core pillars create a distinctive, client-centered model that enables our partners to confidently achieve their objectives with clarity and continuity.
New Indian regulations (UCPMP and Section 194R) now require pharmaceutical companies to replace promotional gifts with ethical, transparent engagement to maintain credibility.
Hippocratic Pharma Research LLP turns these regulatory changes into opportunities by shifting client focus from promotion to genuine scientific and educational value for doctors.
The firm provides ethical platforms like International Fellowships, CME/CPD events, and compliant content creation to facilitate valuable scientific exchange with doctors.
Hippocratic Pharma Research LLP defines compliant financial mechanisms, ensuring pharma companies can transparently pay for professional services and accurately manage tax deductions like Section 194R.
Ultimately, the company acts as a compliant partner, using robust documentation and digital oversight to mitigate client risk, protect reputations, and ensure all industry engagement remains strategic and ethical.
Hippocratic Pharma Research LLP simplifies the complex process of gaining Fellowship or Membership in leading International Medical Associations by handling the entire documentation and submission process for Health Care Professionals (HCPs). This service provides you with verified, prestigious global credentials and networking access, ensuring your commitment to continuous professional growth is recognized worldwide, thereby directly enhancing your clinical credibility and career trajectory without administrative burden.
In light of the new regulatory landscape, particularly UCPMP 2024 and Section 194R, Hippocratic Pharma Research LLP (HPR) acts as your strategic partner to ensure integrity in post-market activities. We transform complex, real-world data into proactive safety and performance insights through our Real-World Evidence (RWE) Post-Market Surveillance (PMS) programs. These programs are built on ethical leadership and a governance-first approach, featuring transparent, Fair Market Value (FMV)-based engagements that strictly comply with new guidelines. By unifying diverse data sources and applying expert medical oversight, we provide actionable insights and timely safety signals without promotional influence, helping you safeguard patients and confidently guide your post-market strategies.
Where rigorous science meets compassionate innovation. Our CME programs are designed to empower healthcare professionals with up-to-date knowledge, practical skills, and evidence-based practices that translate into safer, more effective patient care. Guided by our core motto “evidence you can act on, speed you can trust”—HPR delivers CME experiences that are scientifically rigorous, ethically grounded, and aligned with real-world clinical needs.
Cardiology and Vascular MedicineOncology and HaematologyNeurology and NeurosciencesEndocrinology and Metabolic MedicineRespiratory and Critical Care MedicineInfectious Diseases and ImmunologyNephrology and UrologyGastroenterology and HepatologyRheumatology and Musculoskeletal MedicinePaediatrics and NeonatologyDermatology and VenereologyPsychiatry, Psychology, and Behavioral HealthOncology Supportive Care and Palliative MedicineGeriatrics and GerontologyGlobal Health and Public Health MedicinePharmacology, Pharmacovigilance, and Drug SafetyCell and Gene TherapiesDermatologyObesityOpthalmologyRare DiseasePulmonologyWomen’s HealthMedical DevicesOrphan/Rare Disease
